I have been admittedly skeptical of INO recently. But, I am feeling pretty damn good about loading up. Looking into moving funds to INO

Thank you for simplifying this. I completely understand now. I appreciate it!

Kim is slowly convincing me that INO might be that elusive grand slam. Time will tell though

Ok, if you are so inclined to point out my misinformation. Why don't you clarify what the 10k is for? When I read 300M to 600M I translate that as an INCREASE aka dilution. Enlighten me please. I am sure I am not the only who interprets the 10K this way...


Unlike others here, I am open to criticism and learning!

Proxy Statement: Shareholders to vote on another dilution from 300,000,000 to 600,000,000 authorised shares.

The board is in favor of dilution.

I remain long however I am considering selling on the open as I just don't know what this will do to pps (how low will it go??)


Side Note: Kim states, in a nonchalant manner, that INO is continuously involved in/or discussing large pharma partnerships. It's almost as if he is bragging about it and telling shareholders that he is not willing to sell out. I like his pride and confidence, however, this dilution could very well represent INO's last major independent mode of financing. In other words, it's make or break!

GLTA

So how is it going over here INO fan boys? Are you at the moon yet? lol. Are you at $10 pps yet?? come on MONYMONY start the pumping or this is going red <.50

If INO went bankrupt, MONYMONY would be on some board saying " TO THE MOON WE GO" "PPS OF $100 SOON!!!! I AM RICH BITCH!!!!"


You are so pathetic but keep it going b/c you make me laugh

Excellent, informative post. My comments on Hep C trial were definitely misguided. My point was, INO needed the data to be conclusive to get the ball rolling sort of speak. yes Chrontech owns the Hep C IP, but INO was joint venture thus joint risk.


Again, thanks for the info!

I am thinking high .40's I think the shockwave has passed. Actually could have been worse. But with dilution, I guess this is already hammered down.

The following is my OPINION only....

As I mentioned in the previous months leading up to data release, INO needed the Hep C data to be EPIC to create visibility with synthetic DNA technology. INO's only revenue generating asset is Electroporation. At this point, they will most likely DISCONTINUE HEP C clinical trial, and proceed with other pipelines. Problem is, they just diluted, stock dipped 10-20%, now that cash pile will be depleted to proceed with R&D. In a nutshell, this bio will most likely be one of the 99% that fail. If I was Kim, I would partner in order to create financial backing for R&D. INO is running out of financing options IMO.

With that said, as a prof in the medical field, I am intrigued with their technology. Emotionally, I want INO to be groundbreaking not just for my trading accounts, but for the future of medicine etc.

Bio is INCREDIBLY DIFFICULT AND CUT THROAT, just remember this going forward folks. Have a good day and good luck with your trades.

hate to say it but you guys put all of your eggs in one basket. I am down from .53 too but on house money. I ALWAYS TAKE profits at >5%. Recycle with house money. It lowers your risk.